Abiopharma

🔍 AHRENDTS ANGELA J (Director)

Company: RALPH LAUREN CORP (RL)

Report Date: 2026-07-30

Detailed Transactions and Holdings:

• Acquired 458 shares of Class A Common Stock (Direct)
  Date: 2026-07-30 | Code: A | equity_swap_involved: 0 | shares_owned_after: 11,021.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: Represents shares of the Issuer's Class A Common Stock issued to the Reporting Person as restricted stock units granted under the Issuer's 2019 Long-Term Stock Incentive Plan. These restricted stock units will vest on July 30, 2027, subject to the Reporting Person's continued service through the 2027 Annual Meeting of Stockholders.
• F2: The total also reflects a deduction for cash paid in lieu of approximately 0.02 fractional shares of the Issuer's Class A Common Stock upon vesting of previously-granted restricted stock units.